GRAIL, Inc.
GRAL · Services Medical Laboratories
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Summe Gregory L: Form 4
Insider disclosure · Filed · Report period 15 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- GRAL · 384747101 - COMMON STOCK
Company details and SEC sources
CIK 0001699031 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- GRAL on Nasdaq
- SEC industry group
- Services Medical Laboratories (Industrial Applications and Services)
- Business address
- 250 S. Mathilda Avenue, Suite 100, Sunnyvale, CA, 94086
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- GRAIL, LLC (to 12 Jun 2024)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields